The Real Reason Shadow AI Is Spreading  - Summary - MDSpire
Commentary & Perspectives

The Real Reason Shadow AI Is Spreading 

  • By

  • Sean Blake

  • May 12, 2026

  • 5 min

Share

Shadow AI has become a significant aspect of biopharma R&D as scientists rely on public AI tools due to insufficient support from official systems. A 2025 Sapio Sciences study reveals that only 7% of scientists can customize assays in their electronic lab notebooks (ELNs), and just 5% can analyze results independently. This gap often leads to scientists using personal accounts for AI support, moving scientific reasoning outside organizational oversight, which poses risks to research integrity. To address these challenges, organizations need to architect new systems like the AI Lab Notebook (AILN) that integrate AI capabilities directly into the research workflow to enhance scientific decision-making and compliance.

Original Source(s)

Related Content